✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Vista Pharmaceuticals Ltd.

VISTAPH

Market Cap
₹68 Cr.
P/E
0.00

Vista Pharmaceuticals Ltd.

  • Vista Pharma
  • JFL Life Sciences
  • Godavari Drugs
FAQs on Vista Pharmaceuticals Ltd. Shareprice

Vista Pharma has given lower returns compared to its competitors.
Vista Pharma has grown at ~7.66% over the last 2yrs while peers have grown at a median rate of 14.0%

There is insufficient historical data to gauge this.
Latest PE of Vista Pharma is 0

View FAQ's On Business
Growth Table
  • Vista Pharmaceuticals Ltd.
  • JFL Life Sciences
  • Godavari Drugs
Balance Sheet
  • Vista Pharmaceuticals Ltd.
  • JFL Life Sciences
  • Godavari Drugs
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Vista Pharmaceuticals Ltd.
  • JFL Life Sciences
  • Godavari Drugs
Cash Flow
  • Vista Pharmaceuticals Ltd.
  • JFL Life Sciences
  • Godavari Drugs
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Vista Pharmaceuticals Ltd.
  • JFL Life Sciences
  • Godavari Drugs
Quarterly Results
  • Vista Pharmaceuticals Ltd.
  • JFL Life Sciences
  • Godavari Drugs
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Vista Pharmaceuticals Ltd. Financials

Balance sheet of Vista Pharma is strong.
It shouldn't have solvency or liquidity issues.

The debt of Vista Pharma is decreasing.
Latest debt of Vista Pharma is ₹4.21 Crs as of Sep-24.
This is less than Mar-24 when it was ₹7.8 Crs.

Yes, profit is increasing.
The profit of Vista Pharma is -₹3.06 Crs for TTM, -₹4.51 Crs for Mar 2024 and -₹5.66 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vista Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech